BEVACIZUMAB IN REAL LIFE PATIENTS WITH RECURRENT GLIOBLASTOMA: BENEFIT OR FUTILITY?

被引：0
|
作者：
Smolenschi, Cristina [1 ]
Colomba, Emeline [1 ]
Rassy, Elie [1 ]
Lezghed, Naima [2 ]
Kettab, Mohamed [1 ]
Louvel, Guillaume [1 ]
Garcia, Gabriel [2 ]
Cheaib, Bianca [1 ]
Bockel, Sophie [2 ]
Pallud, Johan [3 ]
Dezamis, Edouard [3 ]
Copaciu, Razvan [4 ]
Knafo, Steven [1 ]
Ammari, Samy [1 ]
Dhermain, Frederic [2 ]
Domont, Julien [1 ]
Martanovschi, Larisa [1 ]
Mahmoud, Fekih [1 ]
Dumont, Sarah [2 ]
机构：
[1] Gustave Roussy, Paris, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Ctr Hosp St Anne, Paris, France
[4] Hop Bicetre, Paris, France
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NCOG-19
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [1] Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
    Smolenschi, Cristina
    Rassy, Elie
    Pallud, Johan
    Dezamis, Edouard
    Copaciu, Razvan
    Parker, Fabrice
    Garcia, Gabriel
    Lezghed, Naima
    Colomba, Emeline
    Khettab, Mohamed
    Ammari, Sami
    Fekhi, Mohamed
    Martanovschi, Larisa
    Benadhou, Lina
    Knafo, Steven
    Guyon, David
    Cheaib, Bianca
    Dhermain, Frederic
    Dumont, Sarah Naomie
    [J]. JOURNAL OF NEUROLOGY, 2023, 270 (05) : 2702 - 2714
  • [2] Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
    Cristina Smolenschi
    Elie Rassy
    Johan Pallud
    Edouard Dezamis
    Razvan Copaciu
    Fabrice Parker
    Gabriel Garcia
    Naima Lezghed
    Emeline Colomba
    Mohamed Khettab
    Sami Ammari
    Mohamed Fekhi
    Larisa Martanovschi
    Lina Benadhou
    Steven Knafo
    David Guyon
    Bianca Cheaib
    Frederic Dhermain
    Sarah Naomie Dumont
    [J]. Journal of Neurology, 2023, 270 : 2702 - 2714
  • [3] BENEFIT OF BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA. RESULTS OF 81 PATIENTS FROM A SINGLE INSTITUTION
    Absalyamova, O.
    Kobiakov, G.
    Agabekyan, G.
    Poddubsky, A.
    Belyashova, A.
    Lodygina, K.
    Absalyamov, A.
    Kobiakov, N.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 69 - 69
  • [4] Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
    Beige, A. V. A.
    Ghiringhelli, F.
    Vincent, J.
    Lecuelle, J.
    Truntzer, C.
    Farah, W.
    Borsotti, F.
    Mazilu, I.
    Ilie, S. M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S523 - S523
  • [5] Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study
    Beige, Alexandre
    Ghiringhelli, Francois
    Lecuelle, Julie
    Truntzer, Caroline
    Truc, Gilles
    Vincent, Julie
    Farah, Walid
    Borsotti, Francois
    Mazilu, Irina
    Ilie, Silvia Mihaela
    [J]. ANTICANCER RESEARCH, 2022, 42 (12) : 5847 - 5858
  • [6] REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA
    Chahal, Manik
    Harrison, Rebecca
    Mhurchu, Elaine Ni
    Thiessen, Brian
    [J]. NEURO-ONCOLOGY, 2022, 24 : 200 - 200
  • [7] BEVACIZUMAB AND IRINOTECAN IN THE TREATMENT OF PATIENTS WITH RECURRENT GLIOBLASTOMA
    Naskhletashvili, D. R.
    Gorbounova, V.
    Bychkov, M.
    Bekyashev, A.
    Karakhan, V.
    Aloshin, V.
    Fu, R.
    Moskvina, E.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 59 - 59
  • [8] Bevacizumab residual concentration for recurrent glioblastoma patients
    Tabouret, E.
    Rousseau, B.
    Barrie, M.
    Thiebault, L.
    Chinot, O.
    Hulin, A.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 26 - 26
  • [9] Bevacizumab in recurrent glioblastoma
    Martinez, Nina L.
    Glass, Jon
    Shi, Wenyin
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S162 - S163
  • [10] REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A LARGE REAL-LIFE EXPERIENCE
    Caccese, Mario
    Cerretti, Giulia
    Padovan, Marta
    Zagonel, Vittorina
    Lombardi, Giuseppe
    [J]. NEURO-ONCOLOGY, 2021, 23 : 71 - 71
12345